Recent Finacing
Recent Raise
Okogen is a San Diego-based biotech developing ophthalmic anti-infective therapeutics; its lead candidate OKG-0301 is a ranpirnase eye formulation in clinical development for adenoviral conjunctivitis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Okogen.
